Inhibrx Biosciences, Inc. (INBX) quarterly income statement — complete revenue, gross profit & net income history
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 | Q2'21 |
|---|
| Sales/Revenue | 0 | 0 | 0 | 1.3M | 0 | 100K | 0 | 100K | 0 | 1.63M | 119K | 30K | 17K | 274K | 278K | 711K | 915K | 2.84M | 2.51M | 918K |
| Revenue Growth % | - | -100% | - | 1200% | - | -93.88% | -100% | 233.33% | -100% | 496.35% | -57.19% | -95.78% | -98.14% | -90.34% | -88.92% | -22.55% | 6.03% | 2.16% | -56.95% | -72.47% |
| Cost of Goods Sold | 537K | 564K | 0 | 662K | 675K | 689K | 760K | 0 | 360K | 298K | 0 | 295K | 722K | 720K | 719K | 29.91M | 0 | 0 | 0 | 0 |
| COGS % of Revenue | - | - | - | 50.92% | - | 689% | - | - | - | 18.24% | - | 983.33% | 4247.06% | 262.77% | 258.63% | 4206.19% | - | - | - | - |
| Gross Profit | -537K | -564K | 0 | 638K | -675K | -589K | -760K | 100K | -360K | 1.34M | 119K | -265K | -705K | -446K | -441K | -29.2M | 915K | 2.84M | 2.51M | 918K |
| Gross Margin % | - | - | - | 49.08% | - | -589% | - | 100% | - | 81.76% | 100% | -883.33% | -4147.06% | -162.77% | -158.63% | -4106.19% | 100% | 100% | 100% | 100% |
| Gross Profit Growth % | 20.44% | 4.24% | 100% | 538% | -87.5% | -144.09% | -738.66% | 137.74% | 48.94% | 399.55% | 126.98% | 99.09% | -177.05% | -115.73% | -117.58% | -3280.28% | 105.87% | 2.16% | 117.9% | 105.87% |
| Operating Expenses | 30.39M | 30.36M | 33.81M | 28.03M | 42.23M | 49.34M | 46.04M | 161M | 73.47M | 89.63M | 45.95M | 41.07M | 43.78M | 35.77M | 30.28M | 35.31M | 29.93M | 22.24M | 21.31M | 20.72M |
| OpEx % of Revenue | - | - | - | 2155.92% | - | 49339% | - | 160998% | - | 5485.01% | 38610.08% | 136913.33% | 257547.06% | 13056.2% | 10892.45% | 4965.96% | 3271.26% | 784.2% | 849.64% | 2256.97% |
| Selling, General & Admin | 5.7M | 5.57M | 5.28M | 6.42M | 6.02M | 16.66M | 7.8M | 93.37M | 9.87M | 7.79M | 7.89M | 7.21M | 6.4M | 5.32M | 5.35M | 5.4M | 5.05M | 3.65M | 2.85M | 2.85M |
| SG&A % of Revenue | - | - | - | 494% | - | 16661% | - | 93366% | - | 476.5% | 6629.41% | 24033.33% | 37629.41% | 1942.7% | 1923.38% | 759.77% | 552.02% | 128.53% | 113.56% | 310.78% |
| Research & Development | 24.69M | 25.35M | 28.54M | 22.27M | 36.88M | 33.37M | 38.23M | 67.63M | 63.59M | 81.84M | 38.06M | 33.86M | 37.39M | 30.45M | 24.93M | 29.91M | 24.89M | 18.61M | 18.48M | 17.9M |
| R&D % of Revenue | - | - | - | 1712.85% | - | 33367% | - | 67632% | - | 5008.51% | 31980.67% | 112880% | 219917.65% | 11113.5% | 8969.06% | 4206.19% | 2720.77% | 656.38% | 737.04% | 1950.11% |
| Other Operating Expenses | 0 | -564K | 0 | -662K | -675K | -689K | 0 | 0 | 0 | 0 | 0 | 0 | -1000K | -1000K | -1000K | 17K | -14K | 0 | -1K | 5K |
| Operating Income | -30.93M | -30.92M | -33.81M | -27.39M | -42.9M | -49.93M | -46.8M | -160.9M | -73.83M | -88.29M | -45.83M | -41.34M | -43.77M | -35.5M | -30M | -34.6M | -29.02M | -19.4M | -18.8M | -19.8M |
| Operating Margin % | - | - | - | -2106.85% | - | -49928% | - | -160898% | - | -5403.24% | -38510.08% | -137796.67% | -257447.06% | -12956.2% | -10792.45% | -4865.96% | -3171.26% | -684.2% | -749.64% | -2156.97% |
| Operating Income Growth % | 27.91% | 38.06% | 27.75% | 82.98% | 41.89% | 43.45% | -2.12% | -289.22% | -68.68% | -148.7% | -52.74% | -19.49% | -50.83% | -82.95% | -59.58% | -74.72% | -56.36% | -13.43% | -20.84% | -15.34% |
| EBITDA | -30.39M | -30.36M | -33.23M | -26.73M | -42.23M | -49.24M | -46.04M | -160.42M | -73.47M | -87.99M | -45.52M | -41.04M | -43.47M | -34.78M | -29.28M | -34.27M | -28.67M | -19.1M | -18.5M | -19.5M |
| EBITDA Margin % | - | - | - | -2056% | - | -49239% | - | -160422% | - | -5385.01% | -38254.62% | -136813.33% | -255711.76% | -12693.43% | -10533.81% | -4820.39% | -3133.66% | -673.38% | -737.72% | -2124.51% |
| EBITDA Growth % | 28.03% | 38.34% | 27.82% | 83.34% | 42.52% | 44.04% | -1.13% | -290.85% | -69% | -152.99% | -55.45% | -19.76% | -51.61% | -82.12% | -58.27% | -75.73% | -56.97% | -13.39% | -20.86% | -15.28% |
| D&A (Non-Cash Add-back) | 537K | 564K | 583K | 661K | 675K | 689K | 760K | 476K | 360K | 298K | 304K | 295K | 295K | 720K | 719K | 324K | 344K | 307K | 299K | 298K |
| EBIT | -30.93M | -30.92M | -32.08M | -25.51M | -40.62M | -47.87M | -43.86M | 1.86B | -70.58M | -88.29M | -43.64M | -39.14M | -41.35M | -35.57M | -29.98M | -34.58M | -28.98M | -19.41M | -18.8M | -19.8M |
| Net Interest Income | -2.5M | -1.87M | -1.4M | -1.02M | -360K | 2M | 2.89M | -2.62M | -4.83M | -3.53M | -5.83M | -5.49M | 0 | 0 | 0 | -3.15M | -2.27M | -1.78M | -1.78M | -914K |
| Interest Income | 1.01M | 1.31M | 1.78M | 2.12M | 2.33M | 2M | 2.89M | 2.74M | 3.3M | 4.7M | 2.32M | 2.41M | 5.08M | 5.34M | 5.34M | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 3.51M | 3.19M | 3.18M | 3.14M | 2.69M | 0 | 0 | 5.36M | 8.13M | 8.22M | 8.15M | 7.91M | 5.08M | 5.34M | 5.34M | 3.15M | 2.27M | 1.78M | 1.78M | 914K |
| Other Income/Expense | -2.51M | -1.91M | -1.44M | -1.26M | -410K | 2.06M | 2.93M | 2.02B | -4.88M | -5.32M | -5.96M | -5.71M | -5.15M | -5.42M | -5.32M | -3.13M | -2.24M | -1.78M | -1.78M | -909K |
| Pretax Income | -33.44M | -32.83M | -35.26M | -28.65M | -43.31M | -47.87M | -43.86M | 1.86B | -78.71M | -93.61M | -51.79M | -47.05M | -48.92M | -40.92M | -35.33M | -37.73M | -31.25M | -21.19M | -20.58M | -20.71M |
| Pretax Margin % | - | - | - | -2204% | - | -47865% | - | 1858013% | - | -5728.76% | -43518.49% | -156823.33% | -287741.18% | -14932.85% | -12706.83% | -5306.33% | -3415.74% | -747.14% | -820.57% | -2255.99% |
| Income Tax | 0 | 0 | 0 | 2K | 0 | 0 | 0 | 2K | 0 | -4K | 2K | 5K | -225K | -1K | 5.32M | 4K | 2.24M | 0 | 0 | 0 |
| Effective Tax Rate % | 0% | 0% | 0% | -0.01% | 0% | 0% | 0% | 0% | 0% | 0% | -0% | -0.01% | 0.46% | 0% | -15.07% | -0.01% | -7.16% | 0% | 0% | 0% |
| Net Income | -33.44M | -32.83M | -35.26M | -28.65M | -43.31M | -47.87M | -43.86M | 1.86B | -78.71M | -93.6M | -51.79M | -47.05M | -48.69M | -40.91M | -40.65M | -37.73M | -33.49M | -21.19M | -20.58M | -20.71M |
| Net Margin % | - | - | - | -2204.15% | - | -47865% | - | 1858011% | - | -5728.52% | -43520.17% | -156840% | -286417.65% | -14932.48% | -14621.22% | -5306.89% | -3660.22% | -747.14% | -820.57% | -2255.99% |
| Net Income Growth % | 22.79% | 31.4% | 19.62% | -101.54% | 44.97% | 48.86% | 15.3% | 4048.85% | -61.65% | -128.78% | -27.41% | -24.7% | -45.39% | -93.1% | -97.51% | -82.19% | -73.63% | -20.06% | -0.4% | -15.8% |
| Net Income (Continuing) | -33.44M | -32.83M | -35.26M | -28.65M | -43.31M | -47.87M | -43.86M | 1.86B | -78.71M | -93.6M | -51.79M | -47.05M | -39.61M | -40.91M | -40.65M | -37.73M | -33.49M | -21.19M | -20.58M | -20.71M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -2.15 | -2.11 | -2.28 | -1.85 | -2.80 | -3.31 | -2.84 | 125.48 | -1.44 | -1.73 | -1.10 | -1.08 | -1.12 | -0.95 | -1.04 | -0.97 | -0.86 | -0.55 | -0.54 | -0.55 |
| EPS Growth % | 23.21% | 36.25% | 19.72% | -101.47% | -94.44% | -91.33% | -158.18% | 11718.52% | -28.57% | -82.11% | -5.77% | -11.34% | -30.23% | -72.73% | -92.59% | -76.36% | -68.63% | -17.02% | 29.87% | -10% |
| EPS (Basic) | -2.15 | -2.11 | -2.28 | -1.85 | -2.80 | -3.31 | -2.84 | 128.35 | -1.44 | -1.73 | -1.10 | -1.08 | -1.12 | -0.95 | -1.04 | -0.97 | -0.86 | -0.55 | -0.54 | -0.55 |
| Diluted Shares Outstanding | 15.59M | 15.49M | 15.48M | 15.47M | 15.47M | 14.48M | 15.47M | 14.81M | 54.55M | 54.03M | 47.15M | 43.64M | 43.58M | 43.27M | 39.07M | 39.04M | 39.02M | 38.58M | 37.89M | 37.82M |
| Basic Shares Outstanding | 15.59M | 15.49M | 15.48M | 15.47M | 15.47M | 14.48M | 15.47M | 14.48M | 54.55M | 54.03M | 47.15M | 43.64M | 43.58M | 43.27M | 39.07M | 39.04M | 39.02M | 38.58M | 37.89M | 37.82M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |